RenovoRx Files Form D for Exempt Securities Offering
Ticker: RNXT · Form: D · Filed: 2026-04-09T10:19:11-04:00
Sentiment: neutral
Topics: exempt-offering, securities, capital-raise
TL;DR
RenovoRx filed a D for a securities offering, details TBD.
AI Summary
RenovoRx, Inc. filed a Form D on April 9, 2026, to announce an exempt offering of securities. The filing does not specify the dollar amount of the offering or the securities being offered, but it indicates the company's business is in Pharmaceutical Preparations.
Why It Matters
This filing signals RenovoRx, Inc. is seeking capital through an exempt offering, which could fund its operations or expansion in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — Form D filings indicate a capital raise, but the lack of specific details on the offering size and terms makes assessing the immediate risk level difficult.
Key Players & Entities
- RenovoRx, Inc. (company) — Filer of the Form D
- 2026-04-09 (date) — Filing date of the Form D
- 2834 (industry_code) — SIC code for Pharmaceutical Preparations
FAQ
What is the purpose of this Form D filing?
The Form D filing by RenovoRx, Inc. on April 9, 2026, is to notify the SEC of an exempt offering of securities.
What is the CIK number for RenovoRx, Inc.?
The CIK number for RenovoRx, Inc. is 0001574094.
What is the business address of RenovoRx, Inc.?
The business address for RenovoRx, Inc. is 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040.
What is the SIC code associated with RenovoRx, Inc.?
The SIC code for RenovoRx, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When was this Form D filing accepted by the SEC?
This Form D filing was accepted by the SEC on April 9, 2026, at 10:19:11.
From the Filing
EDGAR Filing Documents for 0001465818-26-000003 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form D - Notice of Exempt Offering of Securities: SEC Accession No. 0001465818-26-000003 Filing Date 2026-04-09 Accepted 2026-04-09 10:19:11 Documents 1 Effectiveness Date 2026-04-09 Items Item 06b: Document Format Files Seq Description Document Type Size 1 primary_doc.html D 1 primary_doc.xml D 11567 Complete submission text file 0001465818-26-000003.txt 12775 Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649 RenovoRx, Inc. (Filer) CIK : 0001574094 (see all company filings) EIN. : 271448452 | State of Incorp.: DE | Fiscal Year End: 1231 Type: D | Act: 33 | File No.: 021-579681 | Film No.: 26850164 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)